Shaving for a Cause!

Authored by: Brian Latimer, OneBeacon Government Risks

OBGR’s Christina Phelan, her husband Dave (Team Captain), their son Aidan and I along with 4 friends (including one woman!) represented team Dylan Strong in honor of Dylan Vega (soccer mate and friend of Aidan’s) who is currently battling Non-Hodgkin’s Lymphoma and is thankfully doing well after a recent scare. I also was honored to shave on behalf of IT’s Richard DeHart in remembrance of his cousin Susan, who passed shortly after her 12th birthday. While St. Baldrick’s is still tallying the paper checks, our team raised over $9,000 for our 2016 event!  We had many generous sponsors including family and friends, but especially our OneBeacon family including an amazing $2,000 contribution from the OneBeacon Charitable Trust!!  Our original goal was $5,000, so we totally blew it away this year.

Our event included 17 teams with approximately 125 “shavees” who raised nearly $100,000 locally here in San Antonio!  Numbers are still climbing as there was on-site fundraising, beard selling, silent auction, etc.  Dave and Aidan have participated the last 3 years and this was my 2nd year and we are already looking forward to doing it again in 2017, with the hopes that Christina and my girlfriend, Carol, will shave with us. Dave and Christina’s youngest son Keegan is going to be our moneymaker next year!

St. Baldrick’s tidbits: The St. Baldrick’s Foundation is focused on childhood cancer and funding research for finding a cure.  Worldwide, 175,000 children are diagnosed with cancer each year. And in the U.S., more children die of childhood cancer than any other disease—more than AIDS, asthma, cystic fibrosis, congenital anomalies and diabetes combined.  In the last 20 years, only three new drugs have been approved that were specifically developed to treat children with cancer and sadly, less than 4% of the National Cancer Institute’s budget is solely dedicated to childhood cancer research – this is where St. Baldrick’s works to fill that gap.

 

Discussions — No responses yet